Drug-Drug Interactions in Patients with COVID-19 in Nursing Homes

被引：0
|
作者：
Correard, Florian [1 ]
Couderc, Anne-Laure [2 ]
Arcani, Robin [2 ]
Weiland, Joris [2 ]
Courcier, Anais [2 ]
Berard, Charlotte [1 ]
Miola, Charlene [2 ]
Berbis, Julie [3 ]
Villani, Patrick [2 ]
Daumas, Aurelie [2 ]
机构：
[1] Aix Marseille Univ, Timone Hosp, AP HM, Pharmaceut Expertise & Clin Res Unit,Pharm Dept, Marseille, France
[2] Aix Marseille Univ, Timone & St Marguerite Hosp, AP HM, Internal Med Geriatry & Therapeut Dept,CHU Timone, 264 Rue St Pierre, F-13384 Marseille, France
[3] Aix Marseille Univ, Sch Med, EA 3279, CEReSS Hlth Serv Res & Qual Life Ctr, La Timone Med Campus, Marseille, France
来源：
DRUGS & AGING | 2021年 / 38卷 / 07期
关键词：
D O I：
10.1007/s40266-021-00854-6
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
引用
下载
收藏
页码：633 / 635
页数：3
相关论文
共 50 条
  • [41] COVID-19 Drug Interactions
    Surmelioglu, Nursel
    Demirkan, Kutay
    JOURNAL OF CRITICAL & INTENSIVE CARE, 2020, 11 : 43 - 45
  • [42] Letter to the Editor: Possible Drug-Drug Interactions Between Cannabinoids and Candidate COVID-19 Drugs
    Land, M. Hunter
    MacNair, Laura
    Thomas, Brian F.
    Peters, Erica N.
    Bonn-Miller, Marcel O.
    CANNABIS AND CANNABINOID RESEARCH, 2020, 5 (04) : 340 - 343
  • [43] High rate of major drug-drug interactions of lopinavir-ritonavir for COVID-19 treatment
    Macias, Juan
    Pinilla, Ana
    Lao-Dominguez, Francisco A.
    Corma, Anais
    Contreras-Macias, Enrique
    Gonzalez-Serna, Alejandro
    Gutierrez-Pizarraya, Antonio
    Fernandez-Fuertes, Marta
    Morillo-Verdugo, Ramon
    Trigo, Marta
    Real, Luis M.
    Pineda, Juan A.
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [44] Drug-drug interactions between treatment specific pharmacotherapy and concomitant medication in patients with COVID-19 in the first wave in Spain
    Cantudo-Cuenca, M. D.
    Gutierrez-Pizarraya, Antonio
    Pinilla-Fernandez, Ana
    Contreras-Macias, Enrique
    Fernandez-Fuertes, M.
    Lao-Dominguez, F. A.
    Rincon, Pilar
    Pineda, Juan Antonio
    Macias, Juan
    Morillo-Verdugo, Ramon
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [45] Nirmatrelvir/ritonavir treatment of patients with COVID-19 taking tacrolimus: case series describing the results of drug-drug interactions
    Shen, Dan
    Gong, Yinhua
    Qian, Yulan
    Zhu, Jianguo
    Gao, Jie
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2024, 52 (05)
  • [46] Drug-Drug Interactions and Prescription Appropriateness in Patients with COVID-19: A Retrospective Analysis from a Reference Hospital in Northern Italy
    Cattaneo, Dario
    Pasina, Luca
    Maggioni, Aldo Pietro
    Giacomelli, Andrea
    Oreni, Letizia
    Covizzi, Alice
    Bradanini, Lucia
    Schiuma, Marco
    Antinori, Spinello
    Ridolfo, Annalisa
    Gervasoni, Cristina
    DRUGS & AGING, 2020, 37 (12) : 925 - 933
  • [47] Potential drug-drug interactions associated with drugs currently proposed for COVID-19 treatment in patients receiving other treatments
    Venisse, Nicolas
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2020, 34 (05) : 528 - 529
  • [48] Disease-drug and drug-drug interaction in COVID-19: Risk and assessment
    Kumar, Devendra
    Trivedi, Neerja
    BIOMEDICINE & PHARMACOTHERAPY, 2021, 139
  • [49] Recommendations for the Management of Drug-Drug Interactions Between the COVID-19 Antiviral Nirmatrelvir/Ritonavir (Paxlovid) and Comedications
    Marzolini, Catia
    Kuritzkes, Daniel R.
    Marra, Fiona
    Boyle, Alison
    Gibbons, Sara
    Flexner, Charles
    Pozniak, Anton
    Boffito, Marta
    Waters, Laura
    Burger, David
    Back, David J.
    Khoo, Saye
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 112 (06) : 1191 - 1200
  • [50] Drug-drug interactions in nursing homes: A systematic review and meta-analysis of 136 357 residents
    Mongkhon, Pajaree
    Ashcroft, Darren M.
    Kongkaew, Chuenjid
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 248 - 248
12345